Please login to the form below

Not currently logged in


This page shows the latest Brazil news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy

Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy

The drug has also been approved for the cardiomyopathy indication in Japan, Brazil and Canada.

Latest news

More from news
Approximately 11 fully matching, plus 198 partially matching documents found.

Latest Intelligence

  • BRIC markets BRIC markets

    Economists started grouping Brazil, Russia, India and China (BRIC) together in the early 2000s based on predicted GDP growth rates. ... In contrast, the share of global healthcare spending from Brazil, Russia, India and China (BRIC) has increased from

  • Creating a successful global compliance programme Creating a successful global compliance programme

    Additionally, Brazil’s Clean Companies Act applies strict liability regarding interactions with public officials, and South Korea’s Kim Young-ran Act has adopted a broader definition of public officials that

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Brazil and India all seeking to attract global investment, at the same time as the UK seeks to break away from the EU market.

  • Risky business for pharma Risky business for pharma

    Global risk areas  . China (22%), Russia (16%) and Brazil (16%) led the list of riskiest markets identified by surveyed executives from life science and healthcare companies, but the UK, along with ... Across all sectors, the UK tied with Brazil for

  • The ‘Million Hour Challenge’ The ‘Million Hour Challenge’

    For example, as part of ‘World Simplification Day’, simplification champions in AstraZeneca Brazil launched a ‘Waste Hunter’s Contest’ - an initiative built on lean principles.  This encouraged employees to propose opportunities

More from intelligence
Approximately 7 fully matching, plus 42 partially matching documents found.

Latest appointments

  • IFPMA elects Pfizer’s Ian Read as president IFPMA elects Pfizer’s Ian Read as president

    He subsequently held a number of increasingly senior operational positions across Pfizer's Latin America business, including country manager for Pfizer Brazil and chief financial officer for Pfizer Mexico, before becoming

  • Ferring's Inna Demidova moves to ELC Ferring's Inna Demidova moves to ELC

    ELC plans to open its Moscow office later this year and is eyeing further expansion in Brazil and China soon.

  • Takeda promotes Giles Platford Takeda promotes Giles Platford

    Prior to this he was general manager of Takeda Brazil, leading the acquisition of Multilab, a mid-sized company focused on branded generics and over-the-counter (OTC) products. ... The acquisition made Takeda one of the top 10 pharmaceutical groups

  • Daniel Sterzi joins Kantar Health Spain Daniel Sterzi joins Kantar Health Spain

    Prior to this, he worked for GFK Customer Research France and Vivo (Telefónica Brazil), where he began his career as a marketing analyst.

  • Boehringer's Wolfram Carius to step down Boehringer's Wolfram Carius to step down

    He will leave Boehringer on June 30 as managing director responsible for biopharmaceuticals and production, after a career that included spells in Japan and Brazil.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • New opportunities in emerging markets

    Virtually every emerging market, from Indonesia to Mexico and from China to Brazil, is witnessing an increase in the proportion of patients who now qualify as middle class, and wealth is

  • Deep Dive - MINT: opportunities in ‘frontier’ markets?

    These are the countries he believes are poised for strong economic growth, like the emerging markets of BRIC (Brazil, Russia, India and China) before them.

  • Article: Market access in Brazil

    All eyes on Spinraza. Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil? ... SUS). This is the first agreement in Brazil to include a

  • Video: Living with Diabetes (LATAM)

    Mariel Metcalfe highlights the findings of our syndicated Living with Diabetes LATAM report which was conducted amongst 260 type 2 diabetes patients in Brazil and Mexico and is now available to

  • Growing sustainable business from strong roots

    Furthermore, each tree planted is buddied with an intentionally certified carbon credit associated with protecting the rainforest in the Brazil Amazon, to guarantee the offset.

More from PMHub
Approximately 4 fully matching, plus 33 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...